Insider Transactions last 24 months for Enanta Pharmaceuticals, Inc.  -  NSDQ: ENTA

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Luly Jay R.President and CEO02/12/2026DFDirectCOM6,155$14.25$87,708.75871,871
Luly Jay R.President and CEO02/12/2026AADirectCOM15,200$0.00$0.00878,026
Luly Jay R.President and CEO02/12/2026AADirectCOM4,800$0.00$0.00862,826
Or Yat SunChief Scientific Officer02/12/2026DFDirectCOM3,413$14.25$48,635.25374,854
Or Yat SunChief Scientific Officer02/12/2026AADirectCOM5,225$0.00$0.00378,267
Or Yat SunChief Scientific Officer02/12/2026AADirectCOM1,650$0.00$0.00373,042
Rottinghaus Scott T.Chief Medical Officer02/12/2026DFDirectCOM3,413$14.25$48,635.2525,254
Rottinghaus Scott T.Chief Medical Officer02/12/2026AADirectCOM5,225$0.00$0.0028,667
Rottinghaus Scott T.Chief Medical Officer02/12/2026AADirectCOM1,650$0.00$0.0023,442
Kieffer Tara LynnChief Product Strategy Officer02/12/2026DFDirectCOM3,257$14.25$46,412.2533,925
Kieffer Tara LynnChief Product Strategy Officer02/12/2026AADirectCOM4,987$0.00$0.0037,182
Kieffer Tara LynnChief Product Strategy Officer02/12/2026AADirectCOM1,575$0.00$0.0032,195
Luu BrendanChief Business Officer02/12/2026DFDirectCOM3,257$14.25$46,412.2541,634
Luu BrendanChief Business Officer02/12/2026AADirectCOM4,987$0.00$0.0044,891
Luu BrendanChief Business Officer02/12/2026AADirectCOM1,575$0.00$0.0039,904
Kowalsky Matthew PaulChief Legal Officer02/12/2026DFDirectCOM1,902$14.25$27,103.503,591
Kowalsky Matthew PaulChief Legal Officer02/12/2026AADirectCOM4,175$0.00$0.005,493
Kowalsky Matthew PaulChief Legal Officer02/12/2026AADirectCOM1,318$0.00$0.001,318
Luly Jay R.President and CEO12/05/2025DSDirectCOM4,743$14.23$67,492.89858,026
Or Yat SunChief Scientific Officer12/05/2025DSDirectCOM2,390$14.23$34,009.70371,392
Kieffer Tara LynnChief Product Strategy Officer12/05/2025DSDirectCOM2,106$14.23$29,968.3830,620
Luu BrendanChief Business Officer12/05/2025DSDirectCOM1,394$14.23$19,836.6238,329
Rottinghaus Scott T.Chief Medical Officer12/05/2025DSDirectCOM798$14.23$11,355.5421,792
Trout Harry R. IiiSee Remarks12/05/2025DSDirectCOM542$14.23$7,712.6616,348
Capps Kathleen S.See Remarks12/05/2025DSDirectCOM323$14.23$4,596.298,377
1   2  3  Next Last  You are at page 1 of 3 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust 		Export Table Data to Excel Send to Excel